Robin Lefferts

Investment Opportunity: A Company Dedicated to Protecting Your Hearing

According to the National Institute on Deafness and Other Communication Disorders (NIDCD),…

Robin Lefferts
November 9, 2026

Opportunity: The United States Still Needs A Lot of Domestic Lithium

A few years ago, lithium was the darling of the global investment…

Robin Lefferts
October 29, 2026

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™’s Efficacy; Analysts Reiterate Buy Ratings

An incredible amount of planning and preparation goes into the design of…

Robin Lefferts
October 27, 2026

Lithium: Critical Far Beyond Electric Vehicles, Domestic Sources Needed

Electric vehicles remain lithium’s largest demand engine, but the investment story has…

Robin Lefferts
October 20, 2026

An Undervalued Lithium Resource in Nevada

The lithium market has had its ups and downs over the past…

Robin Lefferts
September 29, 2026

Cardiol Therapeutics: Analysts and Institutions Are In

Ahead of the pivotal Phase III MAVERIC topline results, expected in mid-2027,…

Robin Lefferts
September 24, 2026

CDN Maverick: A Project Generator Approaching A Major Test at Nottaway

Junior mining companies often become associated with one project and one geological…

Robin Lefferts
September 24, 2026

Multiple Projects in an Emerging Mining Jurisdiction

Papua New Guinea (PNG) hosts some of the largest gold-copper systems on…

Robin Lefferts
September 14, 2026

AXIL Brands: A Fundamental Small Cap Growth Story

Small- and micro-cap investment stories are usually built around potential more than…

Robin Lefferts
August 11, 2026

How CardiolRx™ Could Fit Into the Recurrent Pericarditis Treatment Regimen

Recurrent pericarditis (RP) is a debilitating disease in need of better forms…

Robin Lefferts
August 11, 2026

Investment Opportunity: A Company Dedicated to Protecting Your Hearing

Opportunity: The United States Still Needs A Lot of Domestic Lithium

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™’s Efficacy; Analysts Reiterate Buy Ratings

Lithium: Critical Far Beyond Electric Vehicles, Domestic Sources Needed

An Undervalued Lithium Resource in Nevada

Cardiol Therapeutics: Analysts and Institutions Are In

CDN Maverick: A Project Generator Approaching A Major Test at Nottaway

Multiple Projects in an Emerging Mining Jurisdiction

AXIL Brands: A Fundamental Small Cap Growth Story

How CardiolRx™ Could Fit Into the Recurrent Pericarditis Treatment Regimen

Don Kreski

Robin Lefferts

Ryan Allway

Stella Emory

Wilson Augustine

The New Mineral Map of James Bay

Why Washington Keeps Backing Graphite One: Final Ohio Air Permit Clears the Path to a 2027 Investment Decision

Golden Cariboo Advances Next Phase of Drilling at the Halo Deposit

Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network

Sign Up for Our Newsletter